000			02064 a2200553 4500
005			20250514204132.0
264		0	_c20041115
008			200411s 0 0 ger d
022			_a0040-5930
024	7		_a10.1024/0040-5930.61.8.521 _2doi
040			_aNLM _beng _cNLM
100	1		_aThimme, R
245	0	0	_a[Cholestatic liver diseases]. _h[electronic resource]
260			_bTherapeutische Umschau. Revue therapeutique _cAug 2004
300			_a521-7 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Review
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aAntibodies, Antineutrophil Cytoplasmic _xanalysis
650	0	4	_aAnticholesteremic Agents _xtherapeutic use
650	0	4	_aAntipruritics _xtherapeutic use
650	0	4	_aAutoimmune Diseases _xcomplications
650	0	4	_aBile Ducts _xpathology
650	0	4	_aCholagogues and Choleretics _xtherapeutic use
650	0	4	_aCholangiography
650	0	4	_aCholangitis _xcomplications
650	0	4	_aCholangitis, Sclerosing _xcomplications
650	0	4	_aCholestasis _xdiagnosis
650	0	4	_aCholestyramine Resin _xtherapeutic use
650	0	4	_aClinical Enzyme Tests
650	0	4	_aDiagnosis, Differential
650	0	4	_aHepatitis, Autoimmune _xcomplications
650	0	4	_aHumans
650	0	4	_aImmunosuppression Therapy
650	0	4	_aInflammatory Bowel Diseases _xcomplications
650	0	4	_aLiver Cirrhosis _xetiology
650	0	4	_aLiver Cirrhosis, Biliary _xdiagnosis
650	0	4	_aLiver Transplantation
650	0	4	_aNaloxone _xtherapeutic use
650	0	4	_aNaltrexone _xtherapeutic use
650	0	4	_aNarcotic Antagonists _xtherapeutic use
650	0	4	_aOndansetron _xtherapeutic use
650	0	4	_aPlasmapheresis
650	0	4	_aUrsodeoxycholic Acid _xtherapeutic use
700	1		_aOpitz, O G
700	1		_aBlum, H E
700	1		_aKreisel, W
773	0		_tTherapeutische Umschau. Revue therapeutique _gvol. 61 _gno. 8 _gp. 521-7
856	4	0	_uhttps://doi.org/10.1024/0040-5930.61.8.521 _zAvailable from publisher's website
999			_c15150088 _d15150088